The influence of medication on salivary flow of the elderly: Preliminary study

Gerodontology

Volumn 27, Issue 4, 2010, Pages 278-282

  Scelza, Miriam F Zaccaro ^a   De Freitas Silva, Danielle ^b   Kwaku Ahiadzro, Nutifafa ^a   Da Silva, Licinio Esmeraldo ^a   Scelza, Pantaleo ^c  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Health Corp of Fire Department   (Brazil)

^c Brazilian Army Dental Corps   (Brazil)

Author keywords

Elderly; Medication; Stimulated salivary flow; Unstimulated salivary flow

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; GASTROINTESTINAL AGENT; THYROID HORMONE; VITAMIN;

AGED; ARTICLE; DRUG EFFECT; DRUG THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGED; PHARMACOLOGY; RISK FACTOR; SALIVA; SECRETION; TIME;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTICOAGULANTS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR AGENTS; DRUG THERAPY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHARMACOLOGY; RISK FACTORS; SALIVA; SECRETORY RATE; THYROID HORMONES; TIME FACTORS; VITAMINS;

EID: 78651283102     PISSN: 07340664     EISSN: 17412358     Source Type: Journal    
DOI: 10.1111/j.1741-2358.2009.00326.x     Document Type: Article

References (17)

1. Hand AR. Salivary glands. In: Nanci A, Ten Cate AR eds. Oral Histology: Development, Structure, and Function, 7th edn. St Louis, USA: Mosby, 2007: 290-312.
2. Sreebny LO. Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140-161.
3. National Institute of Dental Research. Saliva: a promising diagnostic and monitoring tool. J Am Dent Assoc 1994; 125: 867-868.
4. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth, 2nd edn. Gerodontology 1997; 14: 33-47.
5. Janket SJ, Jones J, Rich S, et al. The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 223-230.
6. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc 2002; 50: 535-543.
7. Nagler RM, Hershkovich O. Relationships between age, drugs, oral sensorial complaints and salivary profile. Arch Oral Biol 2005; 50: 7-16.
8. Narhi TO, Meurman JH, Ainamo A, et al. Association between salivary flow rate and the use of systemic medication among 76, 81 and 86 year-old inhabitants in Helsinki, Finland. J Dent Res 1992; 71: 1875-1880.
9. Screebny LM, Valdini A, Yu A. Xerostomia. Part II. Relationship to non-oral symptoms, drugs and diseases. Oral Surg OralMed Oral Pathol 1989; 68: 419-427.
10. Handleman SL, Barik JM, Saunders RH, et al. Hyposalivary drug use, whole stimulated salivary flow, and mouth dryness in older, long term care residents. Spec Care Dentist 1989; 9: 12-18.
11. Tenovuo J, Lagerlö F. Saliva. In: Thylstrup A, Fejerskov O eds. Cariologia clínica, 2nd edn. São Paulo, Brazil: Maike, 1995: 17-43.
12. Sreebny LM. Saliva: its role in health and disease. Int Dent J 1992; 42: 287-304.
13. Thomson WM, Chalmers JM, Spencer AJ, et al. Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent 2000; 60: 12-20.
14. Thomson WM, Chalmers JM, Spencer AJ, et al. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology 2006; 23: 205-214.
15. Keith DH, Willam SW. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch oral Biol 1995; 40: 983-989.
16. Wolff A, Zuk-Paz L, Kaplan I. Major salivary gland output differs between users and non-users of specific medication categories. Gerodontology 2008; 25: 210-216.
17. Nederfors T. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J Suppl 1996; 116: 1-70.